These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17307600)

  • 1. Inhibitory effect of alendronate on bone resorption of autogenous free bone grafts in rats.
    Altundal H; Sayrak H; Yurtsever E; Göker K
    J Oral Maxillofac Surg; 2007 Mar; 65(3):508-16. PubMed ID: 17307600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of alendronate on bone formation after autogenous free bone grafting in rats.
    Altundal H; Gursoy B
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):285-91. PubMed ID: 15716833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of alendronate on resorption of the alveolar bone following tooth extraction.
    Altundal H; Güvener O
    Int J Oral Maxillofac Surg; 2004 Apr; 33(3):286-93. PubMed ID: 15287313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
    Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
    J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alendronate enhances osseous healing in a rat calvarial defect model.
    Toker H; Ozdemir H; Ozer H; Eren K
    Arch Oral Biol; 2012 Nov; 57(11):1545-50. PubMed ID: 22795567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosing time-dependent variation of bone resorption by cyclosporin A in rats' femurs.
    Tsuruoka S; Kaneda T; Maeda A; Ioka T; Fujimura A
    Eur J Pharmacol; 2007 Jun; 564(1-3):226-31. PubMed ID: 17362919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative evaluation of the systemic and local alendronate treatment in synthetic bone graft: a histologic and histomorphometric study in a rat calvarial defect model.
    Toker H; Ozdemir H; Ozer H; Eren K
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5 Suppl):S146-52. PubMed ID: 23063391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of local pretreatment with alendronate on healing of replanted rat teeth.
    Komatsu K; Shimada A; Shibata T; Shimoda S; Oida S; Kawasaki K; Nifuji A
    J Periodontal Res; 2008 Apr; 43(2):194-200. PubMed ID: 18302622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of local delivery of alendronate on bone formation in bioactive glass grafting in rats.
    Srisubut S; Teerakapong A; Vattraphodes T; Taweechaisupapong S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):e11-6. PubMed ID: 17656137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption.
    Asaba Y; Hiramatsu K; Matsui Y; Harada A; Nimura Y; Katagiri N; Kobayashi T; Takewaka T; Ito M; Niida S; Ikeda K
    Bone; 2006 Dec; 39(6):1276-82. PubMed ID: 16942925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of osteoporosis and bone resorption of alveoli with alendronate in rat model].
    Wang X; Yang Z; Yu S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 May; 36(3):193-6. PubMed ID: 11812340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of L-threonate on bone resorption by osteoclasts in vitro].
    He JH; Tong NW; Li HQ; Wu J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):225-8. PubMed ID: 15807273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclast activation: potent inhibition by the bisphosphonate alendronate through a nonresorptive mechanism.
    Owens JM; Fuller K; Chambers TJ
    J Cell Physiol; 1997 Jul; 172(1):79-86. PubMed ID: 9207928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rat model for testing pharmacologic treatments of pressure-related bone loss.
    Astrand J; Skripitz R; Skoglund B; Aspenberg P
    Clin Orthop Relat Res; 2003 Apr; (409):296-305. PubMed ID: 12671515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphometric and microscopic evaluation of the effect of a solution of alendronate as an intracanal therapeutic agent in rat teeth submitted to late reimplantation.
    Mori GG; Garcia RB; Gomes de Moraes I; Bramante CM; Bernardineli N
    Dent Traumatol; 2007 Aug; 23(4):218-21. PubMed ID: 17635354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A histopathological investigation on the effect of systemic administration of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the rat mandible.
    Kaynak D; Meffert R; Bostanci H; Günhan O; Ozkaya OG
    J Periodontol; 2003 Sep; 74(9):1348-54. PubMed ID: 14584869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate.
    Tanaka T; Saito M; Chazono M; Kumagae Y; Kikuchi T; Kitasato S; Marumo K
    J Biomed Mater Res A; 2010 May; 93(2):469-74. PubMed ID: 19582838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alendronate is effective to treat bone loss in renal transplantation recipients.
    Lan G; Peng L; Xie X; Peng F; Wang Y; Yu S
    Transplant Proc; 2008 Dec; 40(10):3496-8. PubMed ID: 19100422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats.
    Kim MK; Kim HD; Park JH; Lim JI; Yang JS; Kwak WY; Sung SY; Kim HJ; Kim SH; Lee CH; Shim JY; Bae MH; Shin YA; Huh Y; Han TD; Chong W; Choi H; Ahn BN; Yang SO; Son MH
    J Pharmacol Exp Ther; 2006 Aug; 318(2):555-62. PubMed ID: 16699068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.